Lilly announces details of presentations at 2025 American Association for Cancer Research (AACR) Annual Meeting
Eli Lilly and Company (NYSE: LLY) today announced that preclinical data for agents targeting SMARCA2 (BRM) and multiple KRAS ...
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
The trial results are critical, as it brings Eli Lilly's pill one step closer to becoming a new, needle-free alternative for ...
Eli Lilly & Co. stock outperforms competitors on strong trading day
Shares of Eli Lilly & Co. LLY rallied 3.26% to $864.90 Monday, on what proved to be an all-around great trading session for ...
Organovo closes sale of FXR program to Eli Lilly
Organovo (ONVO) announced the close of the sale of its FXR program, including lead asset FXR314, to Eli Lilly and Company (LLY). The ...
Seeking Alpha2d
LLY Eli Lilly and Company
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally. The company offers Basaglar, Humalog, Humalog Mix 75/ ...
Organovo Sells FXR Program To Eli Lilly
Organovo Holdings Tuesday has completed the sale of its FXR program, including lead asset FXR314, to Eli Lilly and Company (LLY).The transaction, finalized on March 25 ...
5 Reasons It's Not Too Late to Buy Eli Lilly Stock
Eli Lilly (NYSE: LLY) has been around for almost 150 years, finding ways to innovate and grow. The next largest healthcare ...
Open to tie-ups in India for selling Mounjaro: Eli Lilly CEO David Ricks
Eli Lilly is exploring partnerships with Indian pharma firms to market its anti-diabetes and weight loss drug Mounjaro, ...
Eli Lilly: Growth With Higher Margins
Discover why Eli Lilly and Company is set for a strong 2024 with a robust pipeline, solid financials, and strategic growth ...
Better Stock to Buy Right Now: Viking Therapeutics vs. Eli Lilly
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.